Home

The Korea Herald

Latest news

Most Popular

  1. 1

    1 in 3 Koreans live alone, family types becoming diverse

    1 in 3 Koreans live alone, family types becoming diverse
  2. 2

    Korea, Japan finance chiefs vow to tame rampant FX market volatility

    Korea, Japan finance chiefs vow to tame rampant FX market volatility
  3. 3

    US 'incredibly concerned' about suspected NK-Iran military ties

    US 'incredibly concerned' about suspected NK-Iran military ties
  4. 4

    K-pop group's manager dismissed for setting up spycam in theater dressing room

    K-pop group's manager dismissed for setting up spycam in theater dressing room
  5. 5

    K-pop singer lost consciousness after being hit by foul ball, cancels show

    K-pop singer lost consciousness after being hit by foul ball, cancels show
  1. 6

    Korean Muslim YouTuber's plan to build mosque in Incheon goes viral

    Korean Muslim YouTuber's plan to build mosque in Incheon goes viral
  2. 7

    [Kim Seong-kon] Democracy and the future of South Korea

    [Kim Seong-kon] Democracy and the future of South Korea
  3. 8

    Yoon's office denies considering liberal figures for key posts

    Yoon's office denies considering liberal figures for key posts
  4. 9

    Why is Apple Pay struggling to get purchase in Korea?

    Why is Apple Pay struggling to get purchase in Korea?
  5. 10

    Seoul says Fu Bao loan 'not going to happen'

    Seoul says Fu Bao loan 'not going to happen'
지나쌤

Govt. to lower age of eligibility for COVID-19 treatment pills from 65 to 60: PM

By Yonhap

Published : Jan. 21, 2022 - 09:30

    • Link copied

A pharmacist checks boxes containing Paxlovid, COVID-19 treatment pills developed by US pharmaceutical giant Pfizer Inc., at a drugstore in Seoul last Friday, as South Korea began to prescribe and administer COVID-19 treatment pills the same day, starting with patients with a weak immune system and those over the age of 65. (Yonhap) A pharmacist checks boxes containing Paxlovid, COVID-19 treatment pills developed by US pharmaceutical giant Pfizer Inc., at a drugstore in Seoul last Friday, as South Korea began to prescribe and administer COVID-19 treatment pills the same day, starting with patients with a weak immune system and those over the age of 65. (Yonhap)
The government will lower the age of eligibility for COVID-19 treatment pills from 65 to 60 to better contain the spread of the omicron variant, Prime Minister Kim Boo-kyum said Friday.

Kim announced the measure during a COVID-19 response meeting held a day after President Moon Jae-in said omicron has become the dominant strain in the country.

The first batch of Pfizer Inc.'s COVID-19 treatment pills arrived in the country last week to be administered first to those with compromised immune systems and those aged 65 and above. (Yonhap)

More from Headlines